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De novo synthesis of total and ribosomal ribonucleic acids has been studied during the early stages of Artemia sp. devel- 
opment. By in vivo in~~oration studies of ‘ti4C]HCO; an increase has been found in both total and ribosomal RNA 
synthesis post hatching, with a similar distribution of radioactivity and base composition. 
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1. INTRODUCTION 
Nucleotide metabolism and its biosynthesis - as 
components of ribonucleic acids - have been exten- 
sively studied in Artem& sp. [ 1] because of the par- 
ticular features connected with its larval develop- 
ment. Several authors have demonstrated changes 
in nucleic acid concentrations during larval devel- 
opmentof this crustacean [2,31: On the other hand, 
evidence of the capacity of &tern& nauplii to syn- 
thesize de novo purine nucleotides and of the in- 
crease of this synthesis during larval development 
has been reported previously by our laboratory [4]. 
In this paper, we have studied the changes in the 
de novo synthesis of total and ribosomal RNA and 
the base composition of the RNAs during the early 
stages of Arfemia development by in vivo incor- 
poration of [14C]HC05 as a de novo precursor. 
2. MATERIALS AND METHODS 
2.1. Materials 
Artemia cysts were obtained from San Francisco Bay Brand 
Co., Menlo Park, CA. [‘%]HCOS was purchased from The 
Correspondence address: P. Llorente, Instituto Investigaciones 
Biomedicas de1 C.S.I.C., Arzobispo Morcillo 428029 Madrid, 
Spain 
Radiochemical Centre (Amersham, UK). AI1 nonradioactive 
purine bases and their ribonucleotide derivatives were obtained 
from Sigma Chemical Co., St. Louis, MO. Eagle’s Minimal 
Essential Medium containing balanced salt solution was pur- 
chased from Grand Island Biological Co. (GIBCO), Grand 
Island, NY. Other fine chemicals were reagent grade from 
Sigma Chemical Co., or Carlo Erba (Milan, Italy). 
The dried embryos were treated and nauplii grown syn- 
chronously as described [5], except for the salt concentration of 
the growth medium which was diluted 5-fold. Nauplii at dif- 
ferent times of development were incubated for in vivo incor- 
poration studies under the same conditions as in [4], in the 
presence of [‘4C]HCO% (spec. act. 60 Cilmol), at a final con- 
centration of 2 mM. After 3 h of incubation at 30°C, nauplii 
were collected by filtration and washed with 10 mM NaHCO3. 
The different molecular fractions were then obtained as de- 
scribed [6] by standard methods involving homogeneiration in 
0.5 M perchioric acid. The nucleic acid fraction was obtained 
from the acid insoluble material by saline extraction as de- 
scribed [7]. Ribosomal RNA from nauplii of Artemia was 
prepared as described previously 181. The amount of RNA was 
estimated by optical density at 260 nm and its de novo synthesis 
by in vivo incorporation of the de novo RNA precursor and 
subsequent ~gh-performance liquid c~omatographic (HPLC) 
analysis of nucleotides obtained by alkaline hydrolysis. 
The RNAs were selectively hydrolyzed by 0.3 M KOH at 
37’C for 20 h, and 2’- and 3’-RNA nucleotides were analyzed 
by HPLC using a Waters liquid chromatograph (Waters Assoc., 
Milford, MA, USA) 6000-A pump, a U6K injector, a 440 UV 
detector at 254 nm and a~Bondapak Cis column (300 x 4 mm, 
10 pm particles) under isocratic elution conditions. 
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Fig.1. Content and de novo synthesis of total (0) and ribo- 
somal (0) RNAs from Artemia nauplii at different develop- 
ment times. The arrow indicates the moment of hatching. 
3. RESULTS AND DISCUSSION 
The content of total and ribosomal RNAs in- 
creases with the age of the nauplii (fig.1) in a 
qualitatively similar form to the increase obtained 
in the level of labelled RNAs in the presence of 
[14C]HC0: as de novo precursor, with the highest 
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Fig.3. In vivo incorporation of [%Z]HC05 into total (A) and 
ribosomal (B) RNA bases: cytosine (w), uracil (A), guanine (0) 
and adenine (o), from Arfemiu nauplii at different stages of de- 
velopment. The arrows indicate the hatching of the nauplii. 
incorporation of radioactivity taking place in 
20-30-h-old Artemia nauplii under our experimen- 
tal conditions. 
The incorporation of [14C]HC0: into alkali- 
derived RNA nucleotides is shown in fig.2, which 
represents the chromatographic profile of 2’- and 
3 ‘-RNA nucleotides and the radioactivity incor- 
B I 
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Fig.2. HPLC analysis of alkali-derived RNA nucleotides from newly hatched (A), 10 (B), 20 (C) and 30 (D) -h-old Artemia nauplii, 
incubated in the presence of [“‘CIHCO:. Conditions: FBondapak Cls column eluted with 0.1 M KHzP04,2% methanol, pH 4.0, flow 
rate 2 ml/min for 15 min, and then isocratic application of 0.1 M KH2P04, 10% methanol, pH 4.0. 
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porated by newly hatched as well 
as at different developmental times. 
In recently hatched nauplii, label is 
in pyrimidines, while the radioactivity in 
20 h later. Fig.3 shows data 
of of the labelled cytosine, 
and adenine nucleotides and 
ribosomal RNAs. The incorporation increases 
ing Artemia nauplii early and a max- 
is obtained at 20 h post hatching. 
our experimental conditions of 
in 30-h-old nauplii is in 
the absence of 
The distribution of radioactivity incor- 
porated into the 4 types of nucleotides is 
for total and ribosomal RNAs during the 
early development of as shown in 
1. newly hatched nauplii until lo-15 h 
post hatching is detected 
20 h on, an 
corporation and pyrimidine 
nucleotides is and represents approximately 
25% into the 4 base types. 
In our study, the base composition of total and 
ribosomal RNAs at different 
developmental times no differences and 
represents for cytosine, 17% for uracil, 32% 
for guanine and 30% for adenine. On the other 
hand, C content and the (G+ C)/(A+U) 
ratio were 53% and 1.0, respectively, 
for both ribonucleic 
In conclusion, the results 
de novo synthesis the cellular content of 
total and ribosomal 
ing Artemia nauplii development as a function of 
de novo pyrimidine 
and novo purine 20 with un- 
changed is agreement 
of Artemia 
sp. previously In connection 
and with respect in particular to 
value of we may consider 
the crustacean Artemia at low level in phylo- 
genetic scale, its G + C value is 
of other biological systems from mammalian 
Table 1 
Distribution of radioactivity from [‘4C]HCO; into RNA 
nucleotides at different stages in the development of Artemia 
nauplii 
Development* Fraction CMP UMP GMP AMP 
Hatching RNA 63b 31 0 0 
rRNA 62 38 0 0 
10 RNA 52 48 0 0 
rRNA 59 41 0 0 
20 RNA 28 26 25 21 
rRNA 26 25 24 25 
30 RNA 24 21 23 26 
rRNA 26 25 25 24 
a Time of development as hours post hatching 
b Data as percent of radioactivity from HPLC chromatograms 
with respect to total incorporation into 4 types of RNA 
nucleotides 
tissues earlier described [10,l l] and more related to 
that found in yeast or certain bacteria [l 11. 
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